Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1381276rdf:typepubmed:Citationlld:pubmed
pubmed-article:1381276lifeskim:mentionsumls-concept:C0038880lld:lifeskim
pubmed-article:1381276lifeskim:mentionsumls-concept:C1510884lld:lifeskim
pubmed-article:1381276pubmed:issue18lld:pubmed
pubmed-article:1381276pubmed:dateCreated1992-10-8lld:pubmed
pubmed-article:1381276pubmed:abstractTextIn this study, we have determined the ability of suramin to inhibit angiogenesis in the chick chorioallantoic membrane. Suramin alone showed significant angiostatic activity in a dose-related manner. Suramin also potentiated the activity of the angiostatic steroids, cortisol-21-phosphate, 17 alpha-hydroxyprogesterone, tetrahydrocortisol, and tetrahydrocortexolone. The presence of heparin decreased the angiostatic activity of suramin. These results suggest that suramin may decrease tumor growth by inhibiting angiogenesis. These novel findings indicate that suramin, perhaps in combination with angiostatic steroids, may be the basis for important new therapeutic approaches for diseases of neovascularization.lld:pubmed
pubmed-article:1381276pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1381276pubmed:languageenglld:pubmed
pubmed-article:1381276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1381276pubmed:citationSubsetIMlld:pubmed
pubmed-article:1381276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1381276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1381276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1381276pubmed:statusMEDLINElld:pubmed
pubmed-article:1381276pubmed:monthSeplld:pubmed
pubmed-article:1381276pubmed:issn0008-5472lld:pubmed
pubmed-article:1381276pubmed:authorpubmed-author:CollinsD CDClld:pubmed
pubmed-article:1381276pubmed:authorpubmed-author:GagliardoGGlld:pubmed
pubmed-article:1381276pubmed:authorpubmed-author:HaddHHlld:pubmed
pubmed-article:1381276pubmed:issnTypePrintlld:pubmed
pubmed-article:1381276pubmed:day15lld:pubmed
pubmed-article:1381276pubmed:volume52lld:pubmed
pubmed-article:1381276pubmed:ownerNLMlld:pubmed
pubmed-article:1381276pubmed:authorsCompleteYlld:pubmed
pubmed-article:1381276pubmed:pagination5073-5lld:pubmed
pubmed-article:1381276pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:meshHeadingpubmed-meshheading:1381276-...lld:pubmed
pubmed-article:1381276pubmed:year1992lld:pubmed
pubmed-article:1381276pubmed:articleTitleInhibition of angiogenesis by suramin.lld:pubmed
pubmed-article:1381276pubmed:affiliationResearch Service, Veterans Administration Medical Center, Lexington, Kentucky.lld:pubmed
pubmed-article:1381276pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1381276pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1381276pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:1381276pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1381276lld:pubmed